Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2025 Results Conference Call May 8, 2025 4:30 PM ET
Company Participants
Mariann Ohanesian – Senior Director Investor Relations
Alan Auerbach – President & Chief Executive Officer
Jeff Ludwig – Chief Commercial Officer
Heather Blaber – VP of Marketing
Roger Storms – VP of Sales
Maximo Nougues – Chief Financial Officer
Conference Call Participants
Divya Rao – Cowen
Operator
Good afternoon. My name is Sherry, and I will be your conference call operator today. [Operator Instructions] As a reminder, this call is being recorded.
I would now like to turn the conference over to Mariann Ohanesian, Senior Director of Investor Relations for Puma Biotechnology. Thank you. You may begin your conference.
Mariann Ohanesian
Thank you, Sherry. Good afternoon and welcome to Puma’s conference call to discuss our earnings results for the first quarter of 2025. Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and Chairman of the Board of Puma Biotechnology; Maximo Nougues, Chief Financial Officer; Jeff Ludwig, Chief Commercial Officer; Heather Blaber, Vice President of Marketing; and Jeff Storms, Vice President of Sales.
After the close today, Puma issued a news release detailing earnings results for first quarter 2025. That news release, the slides that Jeff will refer to and a webcast of this call are accessible via the homepage and investor sections of our website at pumabiotechnology.com. The webcast and presentation slides will be archived on our website and available for replay for the next 90 days.
Today’s conference call will include statements about Puma’s future expectations, plans and prospects that constitute forward-looking statements for purposes of federal securities laws. Such statements are subject to risks and uncertainties, and actual events and results may differ from those expressed in these forward-looking statements.
For a full discussion of these
Read the full article here
